Serge Belanger Analyst Performance

Senior Analyst at Needham & Company LLC

Serge Belanger is a stock analyst at Needham & Company LLC in the medical sector, covering 31 publicly traded companies. Over the past year, Serge Belanger has issued 75 stock ratings, including buy and hold recommendations. While full access to Serge Belanger's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Serge Belanger's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 207 Last 10 Years
Buy Recommendations: 89.81% 185 Buy Ratings
Companies Covered: 31 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	89.8%	185 ratings
Hold	10.2%	21 ratings
Sell	0.0%	0 ratings

Out of 206 total stock ratings issued by Serge Belanger at Needham & Company LLC, the majority (89.8%) have been Buy recommendations, followed by 10.2% Hold.

Best & Worst Calls

Best Call
0000.0%
AERI
Mar 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
CRXTQ
Mar 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	96.8% of companies on NASDAQ	30 companies
OTCMKTS	3.2% of companies on OTCMKTS	1 company

Serge Belanger, an analyst at Needham & Company LLC, currently covers 31 companies listed on NASDAQ and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 31 companies	100.0%

Serge Belanger of Needham & Company LLC specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 11 companies	35.5%
MED - DRUGS 9 companies	29.0%
PHARMACEUTICAL PREPARATIONS 7 companies	22.6%
MED PRODUCTS 2 companies	6.5%
MED - GENERIC DRG 1 company	3.2%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	3.2%

About Serge Belanger

Serge Belanger joined Needham & Company in 2009, where he covers the Biotechnology sector. Prior to Needham, Serge worked as a research associate at Fulcrum Global Partners and Susquehanna International Group covering the biotech and specialty pharma healthcare sectors. Previously, Serge was part of Adolor Corporation, a biopharmaceutical company, as a senior research scientist, where he was involved with the discovery and development of novel opioid receptor targeted molecules and non-opioid pain therapeutics. Serge graduated from McGill University with a BSc, Biochemistry/Pharmacology, and an MSc, Pharmacology and Therapeutics. He obtained his MBA in Finance from the Stern School of Business at New York University.

Follow on LinkedIn

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
KALV KalVista Pharmaceuticals	9/12/2025	Reiterated Rating	$13.60	$28.00	Buy
CYTK Cytokinetics	9/2/2025	Reiterated Rating	$35.33	$72.00	Buy
OCS Oculis	8/27/2025	Initiated Coverage	$17.53	$36.00	Buy
OMER Omeros	8/15/2025	Reiterated Rating	$4.12		Hold
AMPH Amphastar Pharmaceuticals	8/12/2025	Upgrade	$27.36	$36.00	Buy
LQDA Liquidia Technologies	8/12/2025	Boost Price Target	$24.10	$36.00	Buy
TRVI Trevi Therapeutics	8/8/2025	Lower Price Target	$7.30	$22.00	Buy
HRTX Heron Therapeutics	8/8/2025	Lower Price Target	$1.33	$3.00	Buy
ARQT Arcutis Biotherapeutics	8/7/2025	Boost Price Target	$15.36	$22.00	Buy
VRDN Viridian Therapeutics	8/6/2025	Lower Price Target	$17.22	$34.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
EOLS Evolus	8/6/2025	Reiterated Rating	$8.91	$22.00	Hold
OCUL Ocular Therapeutix	8/5/2025	Boost Price Target	$12.00	$15.00	Buy
BCRX BioCryst Pharmaceuticals	8/4/2025	Reiterated Rating	$8.73	$17.00	Buy
CLSD Clearside Biomedical	7/17/2025	Downgrade	$9.12	$45.00	Hold
BCRX BioCryst Pharmaceuticals	6/25/2025	Reiterated Rating	$9.78	$17.00	Buy
CRMD CorMedix	6/24/2025	Boost Price Target	$16.56	$20.00	Buy
NAMS NewAmsterdam Pharma	6/12/2025	Reiterated Rating	$20.50	$40.00	Buy
LQDA Liquidia Technologies	5/28/2025	Reiterated Rating	$15.60	$25.00	Buy
ARQT Arcutis Biotherapeutics	5/23/2025	Reiterated Rating	$13.66	$20.00	Buy
LQDA Liquidia Technologies	5/21/2025	Reiterated Rating	$17.02	$25.00	Buy
VRDN Viridian Therapeutics	5/20/2025	Reiterated Rating	$13.25	$36.00	Buy
TRVI Trevi Therapeutics	5/20/2025	Reiterated Rating	$6.49	$24.00	Buy
OMER Omeros	5/16/2025	Reiterated Rating	$3.95		Hold
CLSD Clearside Biomedical	5/15/2025	Lower Price Target	$12.81	$45.00	Buy
CYTK Cytokinetics	5/14/2025	Reiterated Rating	$30.61	$72.00	Buy
VRCA Verrica Pharmaceuticals	5/14/2025	Reiterated Rating	$0.50		Hold
MLTX MoonLake Immunotherapeutics	5/13/2025	Reiterated Rating	$40.18	$66.00	Buy
XENE Xenon Pharmaceuticals	5/13/2025	Lower Price Target	$35.85	$55.00	Buy
LQDA Liquidia Technologies	5/12/2025	Reiterated Rating	$15.93	$25.00	Buy
PCRX Pacira BioSciences	5/9/2025	Lower Price Target	$24.90	$30.00	Buy
EOLS Evolus	5/8/2025	Reiterated Rating	$11.80	$22.00	Buy
NAMS NewAmsterdam Pharma	5/8/2025	Lower Price Target	$19.50	$40.00	Buy
VRDN Viridian Therapeutics	5/7/2025	Lower Price Target	$12.03	$36.00	Buy
CRMD CorMedix	5/7/2025	Boost Price Target	$11.16	$15.00	Buy
ESPR Esperion Therapeutics	5/7/2025	Lower Price Target	$0.98	$4.00	Buy
BCRX BioCryst Pharmaceuticals	5/6/2025	Boost Price Target	$11.03	$17.00	Buy
CYTK Cytokinetics	5/2/2025	Reiterated Rating	$42.92	$72.00	Buy
MLTX MoonLake Immunotherapeutics	4/30/2025	Reiterated Rating	$40.18	$66.00	Buy
ESPR Esperion Therapeutics	4/25/2025	Reiterated Rating	$0.88	$5.00	Buy
HRTX Heron Therapeutics	4/11/2025	Reiterated Rating	$1.82	$4.00	Buy

BCRX BioCryst Pharmaceuticals	4/10/2025	Reiterated Rating	$6.77	$15.00	Buy
LQDA Liquidia Technologies	4/10/2025	Reiterated Rating	$12.77	$25.00	Buy
AMPH Amphastar Pharmaceuticals	4/10/2025	Reiterated Rating	$25.23		Hold
EOLS Evolus	4/9/2025	Reiterated Rating	$9.36	$22.00	Buy
CRMD CorMedix	4/9/2025	Reiterated Rating	$6.79	$12.00	Buy
ARQT Arcutis Biotherapeutics	4/9/2025	Reiterated Rating	$13.29	$20.00	Buy
VRCA Verrica Pharmaceuticals	4/9/2025	Reiterated Rating	$0.58		Hold
KALV KalVista Pharmaceuticals	4/8/2025	Reiterated Rating	$11.50	$28.00	Buy
TRVI Trevi Therapeutics	4/8/2025	Reiterated Rating	$5.78	$24.00	Buy
CYTK Cytokinetics	4/8/2025	Reiterated Rating	$35.99	$72.00	Buy
ESPR Esperion Therapeutics	4/8/2025	Reiterated Rating	$1.20	$5.00	Buy
CLSD Clearside Biomedical	4/8/2025	Reiterated Rating	$12.68	$60.00	Buy
NAMS NewAmsterdam Pharma	4/8/2025	Reiterated Rating	$15.86	$42.00	Buy
PCRX Pacira BioSciences	4/8/2025	Reiterated Rating	$22.91	$32.00	Buy
ARQT Arcutis Biotherapeutics	4/3/2025	Reiterated Rating	$16.60	$20.00	Buy
OMER Omeros	4/1/2025	Reiterated Rating	$8.27		Hold
CLSD Clearside Biomedical	3/28/2025	Lower Price Target	$15.45	$60.00	Buy
CRMD CorMedix	3/26/2025	Lower Price Target	$7.34	$12.00	Buy
KALV KalVista Pharmaceuticals	3/26/2025	Reiterated Rating	$12.07	$28.00	Buy
LQDA Liquidia Technologies	3/20/2025	Boost Price Target	$14.92	$25.00	Buy
TRVI Trevi Therapeutics	3/19/2025	Lower Price Target	$6.56	$24.00	Buy
KALV KalVista Pharmaceuticals	3/13/2025	Reiterated Rating	$12.45	$28.00	Buy
OCUL Ocular Therapeutix	3/11/2025	Initiated Coverage	$7.65	$15.00	Buy
TRVI Trevi Therapeutics	3/10/2025	Boost Price Target	$4.30	$25.00	Buy
CLSD Clearside Biomedical	3/6/2025	Reiterated Rating	$14.40	$90.00	Buy
EOLS Evolus	3/5/2025	Reiterated Rating	$14.35	$22.00	Buy
PCRX Pacira BioSciences	2/28/2025	Boost Price Target	$25.38	$32.00	Buy
HRTX Heron Therapeutics	2/28/2025	Reiterated Rating	$2.05	$4.00	Buy
MLTX MoonLake Immunotherapeutics	2/27/2025	Boost Price Target	$42.37	$66.00	Buy
ARQT Arcutis Biotherapeutics	2/26/2025	Reiterated Rating	$12.20	$20.00	Buy
CYTK Cytokinetics	2/6/2025	Reiterated Rating	$46.44	$72.00	Buy
EOLS Evolus	1/21/2025	Reiterated Rating	$13.87	$22.00	Buy
OMER Omeros	1/17/2025	Reiterated Rating	$9.18		Hold
BCRX BioCryst Pharmaceuticals	1/13/2025	Boost Price Target	$7.67	$15.00	Buy
PCRX Pacira BioSciences	1/13/2025	Boost Price Target	$20.64	$30.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.